The role of perioperative systemic therapy in patients with upper tract urothelial carcinoma Alison Birtle, Prof. Dr. med., Lancashire Teaching Hospitals, Lancs, UK | |
Current standards and the role of robotic surgery for the treatment of upper tract urothelial cancer Rajesh Nair, Dr. med., Guy’s and St. Thomas’ Hospital, London, UK
| |
Improving robotic minimal invasive surgery in urological malignancies Henk van der Poel, Prof. Dr. med., Netherlands Cancer Institute, Amsterdam, NL | |
Game Changing Research in Urology Laurence Klotz, Prof. Dr. med., University of Toronto, Toronto, Canada | |
Discussion “Tumour genomic profiling for urogenital malignancies: Benefit or Non-sense?” | |
Pro: Aurelius Omlin, PD Dr. med., Kantonsspital St. Gallen, CH | |
Con: Jörg Beyer, Prof. Dr. med., Inselspital Bern, CH | |
Discussion “Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer: Justified or Not?” | |
Pro: Jochen Walz, Prof. Dr. med., Institut Paoli-Calmettes, Marseille, France | |
Con: Andrew Vickers, Prof. Dr. med., Memorial Sloan Kettering Cancer Center, New York, USA |